Himension Capital Singapore PTE. LTD. lifted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 244.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 205,941 shares of the health services provider's stock after purchasing an additional 146,131 shares during the quarter. Himension Capital Singapore PTE. LTD. owned about 0.12% of Teladoc Health worth $1,872,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of TDOC. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Teladoc Health during the 4th quarter worth about $60,000. Trexquant Investment LP acquired a new position in shares of Teladoc Health during the 4th quarter valued at $2,761,000. Headlands Technologies LLC raised its stake in shares of Teladoc Health by 608.6% in the 4th quarter. Headlands Technologies LLC now owns 15,306 shares of the health services provider's stock worth $139,000 after buying an additional 13,146 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after buying an additional 22,664 shares during the period. Finally, Norges Bank acquired a new stake in shares of Teladoc Health in the fourth quarter valued at $1,618,000. Institutional investors and hedge funds own 76.82% of the company's stock.
Teladoc Health Stock Down 1.8 %
NYSE TDOC traded down $0.13 on Friday, reaching $7.11. The stock had a trading volume of 2,493,309 shares, compared to its average volume of 6,228,158. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a 1 year low of $6.61 and a 1 year high of $15.21. The business has a 50 day moving average price of $9.79 and a 200 day moving average price of $9.70. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of -1.23 and a beta of 1.73.
Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.
Insider Activity at Teladoc Health
In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.95% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on TDOC shares. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a report on Monday, March 3rd. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Piper Sandler cut their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, Bank of America decreased their price target on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a research report on Friday. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $10.94.
Get Our Latest Report on Teladoc Health
Teladoc Health Company Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
